Vir Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Vir Biotechnology has a total shareholder equity of $1.7B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.0B and $369.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.70b |
| Equity | US$1.68b |
| Total liabilities | US$369.81m |
| Total assets | US$2.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VIR *'s short term assets ($1.8B) exceed its short term liabilities ($165.1M).
Long Term Liabilities: VIR *'s short term assets ($1.8B) exceed its long term liabilities ($204.8M).
Debt to Equity History and Analysis
Debt Level: VIR * is debt free.
Reducing Debt: VIR * has no debt compared to 5 years ago when its debt to equity ratio was 4.9%.
Debt Coverage: VIR * has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VIR * has no debt, therefore coverage of interest payments is not a concern.